Thompson NW (University of Michigan, Ann Arbor, MI, USA). Current concepts in the
surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease …

Simple Summary Approximately 30% of patients with multiple endocrine neoplasia type 1
(MEN1) develop the Zollinger–Ellison syndrome (ZES), caused by solitary or multiple …

Objective: The aim of this study was to evaluate the results of pancreatic resection in
pancreatic endocrine neoplasias (PENs) in patients affected by multiple endocrine …

Materials and Methods: A retrospective cohort study in a tertiary academic center. Patients
identified in endoscopic databases were included if they had 2 or more EUS examinations …

About 30% of patients with MEN1 develop a Zollinger-Ellison syndrome. Meanwhile it is well
established that the causative gastrinomas are almost exclusively localized in the …

The natural history of pancreatic endocrine tumors (PETs) in patients with MEN1 is largely
unknown. Recent studies in patients with sporadic PETs show that in a subset, tumor growth …

Forty-nine members of 6 families with multiple endocrine neoplasia type 1 (MEN 1) were
investigated with a standardized meal stimulation test to detect the presence of pancreatic …

Background & Aims: Risk factors of metachronous liver metastases and death are not well
known in patients with the Zollinger–Ellison syndrome and multiple endocrine neoplasia …

Aim: To assess presentation and outcome of pancreaticoduodenal endocrine tumors
(PDETs) in a single center series of multiple endocrine neoplasia type 1 (MEN1) patients …

Background: Only 30% to 40% of patients with Zollinger-Ellison syndrome (ZES) undergoing
operation with curative intent have biochemical cures. The purpose of this analysis was to …